Lab
Laboratorio Clinico Islamar, INC
Laboratorio Clinico Islamar, INC was paid $327K by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 16% of everything it billed.
33Billing provider infoLABORATORIO CLINICO ISLAMAR, INC
ARROYO, PR 00714
ARROYO, PR 00714
33aNPI1831527100assigned 10/24/2013
33bProvider typeClinical Medical Laboratory
28Total paid$327K
24GClaims29,443
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#354 of 777
Median peer was paid$278K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,795 | $19K | |
| 2019 | 2,151 | $15K | |
| 2020 | 2,135 | $17K | |
| 2021 | 5,115 | $72K | |
| 2022 | 5,749 | $89K | |
| 2023 | 6,491 | $62K | |
| 2024incomplete | 5,007 | $53K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 1,463 | 1,344 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | 14% | 3,523 | 3,210 | $45K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 1,836 | 1,707 | $45K |
| 80061 | Lipid panel | 13% | 3,541 | 3,201 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.3% | 4,200 | 3,669 | $24K |
| 80053 | Comprehensive metabolic panel | 7.1% | 3,000 | 2,686 | $23K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.0% | 752 | 658 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.2% | 1,572 | 1,402 | $14K |
| 81000 | 3.9% | 4,200 | 3,724 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.0% | 1,351 | 1,206 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 139 | 136 | $7K |
| 86701 | 1.9% | 784 | 667 | $6K |
21 more codes
| 87582 | 1.3% | 27 | $4K | |
| 85027 | 1.2% | 738 | $4K | |
| 82043 | 1.1% | 698 | $3K | |
| 80050 | General health panel | <1% | 304 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 409 | $2K |
| 82274 | <1% | 125 | $2K | |
| 86328 | <1% | 83 | $2K | |
| 82607 | <1% | 84 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 23 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 37 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 32 | $871.87 |
| 87088 | <1% | 104 | $830.27 | |
| 82570 | <1% | 79 | $396.30 | |
| 84439 | <1% | 41 | $359.04 | |
| 86592 | <1% | 93 | $347.25 | |
| 81001 | <1% | 52 | $116.01 | |
| 84550 | <1% | 18 | $80.33 | |
| 85730 | <1% | 14 | $68.40 | |
| 85610 | <1% | 16 | $53.25 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 77 | $0.48 |
| 87899 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERNANDEZ, GERARDO (DIRECTOR)